Stock comparison
EXACT SCIENCES CORP is 4.4x more valuable than BillionToOne, Inc. by market capitalization ($20.03 B vs $4.51 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
EXAS is larger
EXACT SCIENCES CORP is 4.4x more valuable than BillionToOne, Inc. by market capitalization ($20.03 B vs $4.51 B).
Market value leader
EXAS
EXACT SCIENCES CORP is 4.4x more valuable than BillionToOne, Inc. by market capitalization ($20.03 B vs $4.51 B).
Revenue leader
EXAS
BLLN: $305.11M vs EXAS: $3.25B.
Profit leader
BLLN
BLLN: $7.45M vs EXAS: -$207.95M.
Margin leader
BLLN
BLLN: 2.4% vs EXAS: -6.4% net margin.
| Metric | BLLN | EXAS |
|---|---|---|
| Market cap | $4.51 B | $20.03 B |
| US-listed rank | #1499 | #623 |
| Revenue (latest FY) | $305.11M | $3.25B |
| Net income (latest FY) | $7.45M | -$207.95M |
| Net margin | 2.4% | -6.4% |
| P/E (trailing FY) | 605.0x | - |
| SEC filings | 61 | 1,834 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
EXACT SCIENCES CORP is 4.4x more valuable than BillionToOne, Inc. by market capitalization ($20.03 B vs $4.51 B).
In their latest fiscal years, BillionToOne, Inc. reported $305.11M in revenue while EXACT SCIENCES CORP reported $3.25B.
Full pages: BillionToOne, Inc. and EXACT SCIENCES CORP, or browse the full rankings.